Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization
Heart failure remains a huge societal concern despite medical advancement, with an annual direct cost of over $30 billion. While guideline-directed medical therapy (GDMT) is proven to reduce morbidity and mortality, many eligible patients with heart failure with reduced ejection fraction (HFrEF) are...
Enregistré dans:
Auteurs principaux: | Neal M Dixit, Shivani Shah, Boback Ziaeian, Gregg C Fonarow, Jeffrey J Hsu |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Radcliffe Medical Media
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ca54115097ca404abb834a9b50fca39c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection Fraction
par: Nicholas K Brownell, et autres
Publié: (2021) -
Determinants of gait speed in patients with heart failure with reduced ejection fraction
par: Aylin Tanrıverdi, et autres
Publié: (2021) -
Role of nutritional supplementation in heart failure with reduced ejection fraction
par: Yash Paul Sharma, et autres
Publié: (2021) -
Prescription of Sacubitril/Valsartan in Patients with Heart Failure and Reduced Ejection Fraction Attending an Outpatient Heart Failure Clinic
par: M Rizzo, et autres
Publié: (2020) -
Classification of heart failure: A farewell to ejection fraction?
par: Thomas F. Lüscher
Publié: (2021)